281192-93-6 Usage
General Description
1-BENZYL-3-BROMO-7-AZAINDOLE is a chemical compound with the molecular formula C14H11BrN2. It is a derivative of the indole family and consists of a benzene ring attached to an indole ring with a bromine substituent at the 3-position and a benzyl group at the 1-position. 1-BENZYL-3-BROMO-7-AZAINDOLE is commonly used in organic synthesis and medicinal chemistry as a building block for the synthesis of various biologically active molecules and pharmaceuticals. It has been studied for its potential pharmacological properties, including its anti-inflammatory and anti-cancer activities. Additionally, 1-BENZYL-3-BROMO-7-AZAINDOLE may also serve as a useful tool for understanding the structure-activity relationships of indole-based compounds in drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 281192-93-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,1,1,9 and 2 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 281192-93:
(8*2)+(7*8)+(6*1)+(5*1)+(4*9)+(3*2)+(2*9)+(1*3)=146
146 % 10 = 6
So 281192-93-6 is a valid CAS Registry Number.
281192-93-6Relevant articles and documents
AMIDE SUBSTITUTED THIAZOLES AS PROTEIN SECRETION INHIBITORS
-
, (2019/03/17)
Provided herein are thiazole carboxamide protein secretin inhibitors, such as inhibitors of Sec61, methods for their preparation, related pharmaceutical compositions, and methods for using the same. For example, provided herein are compounds of Formula (I): and pharmaceutically acceptable salts and compositions including the same. The compounds disclosed herein may be used, for example, in the treatment of diseases including inflammation and/or cancer.
APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
-
Paragraph 1697, (2013/04/24)
Disclosed are compounds which inhibit the activity of anti-apoptotic Bc1-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bc1-xL protein.
